• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

Log in
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
www.sages.org

SAGES

Reimagining surgical care for a healthier world

  • Home
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Awards
    • Who Is SAGES?
    • Leadership
    • Our Mission
    • Advocacy
    • Committees
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Committee Rosters
      • SAGES Past Presidents
  • Meetings
    • SAGES NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2026 Scientific Session Call for Abstracts
      • 2026 Emerging Technology Call for Abstracts
    • CME Claim Form
    • SAGES Past, Present, Future, and Related Meeting Information
    • SAGES Related Meetings & Events Calendar
  • Join SAGES!
    • Membership Application
    • Membership Benefits
    • Membership Types
      • Requirements and Applications for Active Membership in SAGES
      • Requirements and Applications for Affiliate Membership in SAGES
      • Requirements and Applications for Associate Active Membership in SAGES
      • Requirements and Applications for Candidate Membership in SAGES
      • Requirements and Applications for International Membership in SAGES
      • Requirements for Medical Student Membership
    • Member Spotlight
    • Give the Gift of SAGES Membership
  • Patients
    • Join the SAGES Patient Partner Network (PPN)
    • Patient Information Brochures
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find A SAGES Surgeon
  • Publications
    • Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Sustainability in Surgical Practice
    • SAGES Stories Podcast
    • Patient Information Brochures
    • Patient Information From SAGES
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • MesSAGES – The SAGES Newsletter
    • COVID-19 Archive
    • Troubleshooting Guides
  • Education
    • Wellness Resources – You Are Not Alone
    • Avoid Opiates After Surgery
    • SAGES Subscription Catalog
    • SAGES TV: Home of SAGES Surgical Videos
    • The SAGES Safe Cholecystectomy Program
    • Masters Program
    • Resident and Fellow Opportunities
      • MIS Fellows Course
      • SAGES Robotics Residents and Fellows Courses
      • SAGES Free Resident Webinar Series
      • Fluorescence-Guided Surgery Course for Fellows
      • Fellows’ Career Development Course
    • SAGES S.M.A.R.T. Enhanced Recovery Program
    • SAGES @ Cine-Med Products
      • SAGES Top 21 Minimally Invasive Procedures Every Practicing Surgeon Should Know
      • SAGES Pearls Step-by-Step
      • SAGES Flexible Endoscopy 101
    • SAGES OR SAFETY Video Activity
  • Opportunities
    • Fellowship Recognition Opportunities
    • SAGES Advanced Flexible Endoscopy Area of Concentrated Training (ACT) SEAL
    • Multi-Society Foregut Fellowship Certification
    • Research Opportunities
    • FLS
    • FES
    • FUSE
    • Jobs Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • OWLS/FLS
You are here: Home / Abstracts / LIRAGLUTIDE IN A TERTIARY BARIATRIC CLINIC: A CASE SERIES

LIRAGLUTIDE IN A TERTIARY BARIATRIC CLINIC: A CASE SERIES

Daniel Ta, BSc, Jerry T Dang, MD, Arya M Sharma, MD, PhD, Shahzeer Karmali, MD, MPH, Renuca Modi, MD. University of Alberta

Introduction: The objective of this study is to demonstrate the use of liraglutide in various patient scenarios in a tertiary bariatric clinic. Liraglutide is a glucagon-like peptide type 1 (GLP-1) analogue. Its efficacy for weight management has been demonstrated in various clinical trials, indicating its potential as a pharmacological option for patients with obesity.

Case Descriptions:

Case 1: A 26-year old female started liraglutide treatment to induce weight loss preoperatively. She sufficiently loss weight and successfully underwent laparoscopic sleeve gastrectomy.

Case 2: A 39-year old female was assessed for obesity. To become eligible for surgery, the patient needed to lose a substantial amount of weight. She began liraglutide treatment and was successfully bridged to laparoscopic Roux-en-Y gastric bypass (RYGB).

Case 3: A 31-year old male started liraglutide with plans to undergo bariatric surgery. However, after successful weight loss, the patient opted to cancel the procedure and remain on long-term liraglutide due to its flexibility in lifestyle and behavior.

Case 4: A 29-year old female started liraglutide and successfully lost weight. However, the patient was paying for liraglutide out of pocket, and was forced to discontinue. As a result, she experienced weight recidivism. The patient elected to go back on liraglutide on a lower dose to decrease cost and was subsequently able to lose weight. She successfully underwent laparoscopic RYGB.

Case 5: A 51-year old female underwent successfully laparoscopic RYGB. However, over the years, she began to experience weight recidivism. When she began liraglutide therapy, her weight recidivism reversed, and she lost weight.

Case 6: A 39-year old female had polycystic ovarian syndrome (PCOS) and infertility. The patient wished to pursue in vitro fertilization (IVF) but was advised to reduce her BMI prior to treatment. She was referred to a bariatric clinic and began liraglutide therapy. She was able to reduce her BMI and successfully underwent IVF shortly after.

Conclusion: This case series provides evidence that liraglutide may potentially be a useful pharmacological option in a bariatric clinic. Patients in our cases tolerated liraglutide well, however, liraglutide has been associated with nausea and vomiting, gastroparesis and esophageal dysmotility. Liraglutide is a useful adjunct in a multispecialty bariatric clinic for weight loss. Liraglutide can be used in various patient scenarios: as a bridge to bariatric surgery, for long-term weight loss or to pursue fertility treatment. Further research on liraglutide should be performed, especially in these various patient scenarios to determine its efficacy.


Presented at the SAGES 2017 Annual Meeting in Houston, TX.

Abstract ID: 94191

Program Number: P148

Presentation Session: Poster Session (Non CME)

Presentation Type: Poster

View this Poster

51

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Pinterest (Opens in new window) Pinterest
  • Click to share on WhatsApp (Opens in new window) WhatsApp
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on Pocket (Opens in new window) Pocket
  • Click to share on Mastodon (Opens in new window) Mastodon
  • Click to share on Threads (Opens in new window) Threads
  • Click to share on Bluesky (Opens in new window) Bluesky

Related


sages_adbutler_leaderboard

Hours & Info

11300 West Olympic Blvd, Suite 600
Los Angeles, CA 90064

1-310-437-0544

[email protected]

Monday – Friday
8am to 5pm Pacific Time

Find Us Around the Web!

  • Bluesky
  • X
  • Instagram
  • Facebook
  • YouTube

Copyright © 2025 · SAGES · All Rights Reserved

Important Links

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals